Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03548766Phase 3Unknown
Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood Doping
Blood DiseaseBlood DopingBlood Transfusion, Autologous+1 more
PrincipalinvestigatorStart date: 2018-09-20

Research Network

Collaboration Network

7 collaborators·21 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Francesco Donati

Laboratorio Antidoping FMSI, Rome, Italy

Moderately Similar
1 trials

Shared therapeutic areas:

Hematologic DiseasesBlood DopingBlood Transfusion, Autologous+1 more

Worked with same sponsors:

Anti-Doping Lab QatarHamad Medical Corporation+3 more
Collaborated on 1 trial
Similarity Score44%

Mohammed Alsayrafi

ADLQ

Moderately Similar
1 trials

Shared therapeutic areas:

Hematologic DiseasesBlood DopingBlood Transfusion, Autologous+1 more

Worked with same sponsors:

Anti-Doping Lab QatarHamad Medical Corporation+3 more
Collaborated on 1 trial
Similarity Score44%

Sven Voss

ADLQ

Moderately Similar
1 trials

Shared therapeutic areas:

Hematologic DiseasesBlood DopingBlood Transfusion, Autologous+1 more

Worked with same sponsors:

Anti-Doping Lab QatarHamad Medical Corporation+3 more
Collaborated on 1 trial
Similarity Score44%

Christophe Raynaud

Sidra Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Hematologic DiseasesBlood DopingBlood Transfusion, Autologous+1 more

Worked with same sponsors:

Anti-Doping Lab QatarHamad Medical Corporation+3 more
Collaborated on 1 trial
Similarity Score44%

Mohamed Yassin

Hamad Medical Corporation

Moderately Similar
4 trials

Shared therapeutic areas:

Hematologic DiseasesBlood DopingBlood Transfusion, Autologous+1 more

Worked with same sponsors:

Anti-Doping Lab QatarHamad Medical Corporation+3 more
Collaborated on 1 trial
Similarity Score44%

Costas Georgakopoulos

ADLQ

Moderately Similar
1 trials

Shared therapeutic areas:

Hematologic DiseasesBlood DopingBlood Transfusion, Autologous+1 more

Worked with same sponsors:

Anti-Doping Lab QatarHamad Medical Corporation+3 more
Collaborated on 1 trial
Similarity Score44%

Yang Xiao, MD

Guangzhou General Hospital of Guangzhou Military Command

Related
5 trials

Shared therapeutic areas:

Hematologic Diseases
Similarity Score8%

Rathi V. Iyer, MD

University of Mississippi Medical Center

Related
1 trials

Shared therapeutic areas:

Hematologic Diseases
Similarity Score8%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Hematologic Diseases
Similarity Score8%

Lori Luck, MD

Drexel University

Related
1 trials

Shared therapeutic areas:

Hematologic Diseases
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03548766Phase 3PrincipalInvestigator

Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood Doping

Blood DiseaseBlood DopingBlood Transfusion, Autologous+1 more
Unknown

All 1 trials loaded